Dow Jones Newswires: Sanofi gets FDA approval for hemophilia drug


Sanofi SA said the U.S. Food and Drug Administration has approved its Altuviiio drug, a once weekly treatment for hemophilia A.

The French pharmaceutical company SAN, -0.04% said this is the first approval of the drug, previously referred to as efanesoctocog alfa, and that regulatory submission in the European Union is expected in the second half of this year.

The FDA had granted priority review to the drug in August and designed it a breakthrough therapy in May.

Write to Adria Calatayud at

This article was originally published by Read the original article here.

Previous articleNetflix drops prices in 30 countries amid password-sharing crackdown: report
Next article: Shares of car-wash chain Mister Car Wash sink as full-year outlook comes up short


Please enter your comment!
Please enter your name here